Arthritis drug may help severely ill COVID-19 patients if given early, study finds

(By Erica Carbajal for Becker’s Hospital Review)

Tocilizumab, a drug used to treat rheumatoid arthritis, may help reduce mortality in critically ill COVID-19 patients if given within the first two days of admission to an intensive care unit, according to a study published in JAMA Internal Medicine.  Continue reading article here…


Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or

Leave a Reply